These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity. Southan C; Thompson E; Lane DA Thromb Haemost; 1986 Oct; 56(2):193-7. PubMed ID: 3643663 [TBL] [Abstract][Full Text] [Related]
47. Release of human and horse fibrinopeptides. Teger-Nilsson AC Acta Chem Scand; 1967; 21(7):1879-86. PubMed ID: 5586735 [No Abstract] [Full Text] [Related]
49. Evidence for localization of polymerization sites in fibrinogen. Kudryk BJ; Collen D; Woods KR; Blombäck B J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342 [No Abstract] [Full Text] [Related]
50. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. Merskey C; Johnson AJ; Lalezari P J Clin Invest; 1972 Apr; 51(4):903-11. PubMed ID: 5014617 [TBL] [Abstract][Full Text] [Related]
51. Analysis of human fibrinopeptides by high-performance liquid chromatography. Kehl M; Lottspeich F; Henschen A Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478 [TBL] [Abstract][Full Text] [Related]
52. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom. Tan NH Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070 [TBL] [Abstract][Full Text] [Related]
53. Retention of thrombin by polytetrafluoroethylene: influence on the adsorption of fibrinogen/fibrin. Schlosser E; Simler R; Hörmann H Biomaterials; 1993 Apr; 14(5):365-70. PubMed ID: 8507780 [TBL] [Abstract][Full Text] [Related]
54. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides. Chang MC; Wang BR; Huang TF Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019 [TBL] [Abstract][Full Text] [Related]
55. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. McKee PA; Mattock P; Hill RL Proc Natl Acad Sci U S A; 1970 Jul; 66(3):738-44. PubMed ID: 5269236 [TBL] [Abstract][Full Text] [Related]
56. The effect of Arvin on reticuloendothelial activity in rabbits. Ashford A; Bunn DR Br J Pharmacol; 1970 Sep; 40(1):37-44. PubMed ID: 5487022 [TBL] [Abstract][Full Text] [Related]
57. Maintenance dose of Arvin. Reid HA Lancet; 1969 May; 1(7604):1048-9. PubMed ID: 4181271 [No Abstract] [Full Text] [Related]
58. Platelet and plasma fibrinogens are identical gene products. Doolittle RF; Takagi T; Cottrell BA Science; 1974 Jul; 185(4148):368-70. PubMed ID: 4834369 [TBL] [Abstract][Full Text] [Related]
59. Separation of the coagulant components of Bothrops jararaca venom. Denson KW; Rousseau WE Toxicon; 1970 May; 8(1):15-9. PubMed ID: 5465746 [No Abstract] [Full Text] [Related]
60. Molecular weight of human fibrinogen derived from phosphorus determinations. Fantl P; Ward HA Biochem J; 1965 Sep; 96(3):886-9. PubMed ID: 5862426 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]